BACCH Laboratories, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-30.
BACCH Laboratories, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 30, 2025. The filing reports $1.81M sold. Its industry group is Other Technology. It names James Mentz (Executive Officer, Director), Richard Allen (Director), Robert Mentz (Executive Officer) (SEC Form D, July 30, 2025).
Is this your company?
Sell to companies like BACCH Laboratories, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns BACCH Laboratories, Inc.
Free to see. No signup.
More on the people and the money behind BACCH Laboratories, Inc., from the filings we hold.
Other Technology raises by companies based in Florida, filed in July 2025, largest first.
Get an email when BACCH Laboratories, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when BACCH Laboratories, Inc. raises, hires or launches. No email unless you switch it on.
Watch BACCH Laboratories, Inc. →Get the full cited report on BACCH Laboratories, Inc.
What the filing shows about BACCH Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BACCH Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives BACCH Laboratories, Inc.'s address as 747 Sw 2ND Avenue, Imb#11, Gainesvile, FL 32601.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on BACCH Laboratories, Inc. See pricing
BACCH Laboratories, Inc. is a registered filer with the SEC (CIK 1471363) and has filed since 2025-06-23. 3 filings are on record, the latest on 2025-07-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
BACCH Laboratories, Inc.'s Form D of 2025-07-30 names James Mentz, Richard Allen, Robert Mentz and 3 more as its officers, directors or promoters.
Its new offerings report $2.62M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3842 filings in Other Technology, totalled by week.
Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering.
James Mentz is named as Executive Officer and Director on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
Richard Allen is named as Director on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
Robert Mentz is named as Executive Officer on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
Benjamin Hoover is named as Director on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
Garrett Gleim is named as Director on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
Edgar Choueiri is named as Executive Officer and Director on the Form D that BACCH Laboratories, Inc. filed with the SEC on 30 July 2025, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2025-07-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about BACCH Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on BACCH Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BACCH Laboratories, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BACCH Laboratories, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind BACCH Laboratories, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for BACCH Laboratories, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/bacch-laboratories-inc-form-d-25000002